Balthaser Kevin

Insider profile

Performance

Overall performance
1.5

Performance over holding periods
1.5
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 24% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Balthaser Kevin's trades of Aclaris Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-09-07 2023-09-06 B Purchase
34,708 +39.5%
63.03
US$707,085
34,708 +39.5% 63.03 US$707,085
2023-03-03 2023-03-03 S Sale
48,003 -33.0%
296.87
US$4,404,649
48,003 -33.0% 296.87 US$4,404,649
2023-03-03 2023-03-02 S Sale
95,676 +0.9%
249.88
US$3,700,549
95,676 +0.9% 249.88 US$3,700,549